Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPELISIB vs ALTHIAZIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPELISIB vs ALTHIAZIDE: Safety Overview

Metric ALPELISIB ALTHIAZIDE
Total FAERS Reports 8,419 183
Deaths Reported 1,271 2
Death Rate 15.1% 1.1%
Hospitalizations 1,705 130
Average Patient Age 58.8 yrs 74.9 yrs
% Female Patients 94.7% 69.9%
FDA Approval Date Apr 24, 2024 N/A
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route ORAL N/A
Marketing Status Prescription N/A